Novavax NVAX announced that the World Health Organization (“WHO”) has granted emergency use listing (“EUL”) to NVX-CoV2601, its updated protein-based COVID vaccine, for use in individuals aged 12 ...

Novavax Inc. could now get its Covid-19 vaccine to nearly 200 more countries. It’s a critical win in the company’s bid to get ...

Listen to this article Gaithersburg-based Novavax Inc. Tuesday announced its Nuvaxovid XBB.1.5 COVID-19 vaccine (NVX-CoV2601) ...

Erin Kissane, a co-founder of the COVID Tracking Project, rolled up her sleeve for the Novavax COVID-19 vaccine in ...

The emergency use listing is based on non-clinical data where the vaccine demonstrated immune responses against variants in ...

"The WHO Emergency Use Listing of our updated protein-based non-mRNA COVID-19 vaccine enables expedited regulatory approvals for its 194 member states and UN procurement agencies, such as UNICEF, ...

The single-target vaccine is aimed at the XBB.1.5 Omicron subvariant of the coronavirus, which was dominant in the U.S. for ...

A lot has changed with COVID-19 vaccines since they first debuted back in December 2020. We’ve seen a few hit the market, one ...

The new contest aims to spur innovation into longer “healthspans” with treatments that can actually reverse age-related ...

The U.S Food and Drug Administration approved the first chikungunya vaccine- Ixchiq Ixchiq is administered as a single dose intra-muscularly for individuals over 18 years of age and older who are ...

Shares of small biotech companies involved in CAR-T therapies plunged Tuesday as the FDA said it was investigating potential ...

Erin Kissane, a co-founder of the COVID Tracking Project, rolled up her sleeve for the Novavax covid-19 vaccine in ...